Using biomarkers to identify and treat schizophrenia
Wednesday, July 11, 2012 - 13:50
in Health & Medicine
Scientists have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.